Evidence map›Paper›PMID 21482728›Full record

ReviewClinical microbiology reviews2011

Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Linda M Parsons, Akos Somoskövi, Cristina Gutierrez, Evan Lee, C N Paramasivan, Alash'le Abimiku, Steven Spector, Giorgio Roscigno, John Nkengasong

Open access · greenAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 260 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
260citing papers in PubMed, 6 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

260 citing papers in PubMed, 6 syntheses or guidelines pooled it, 525 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Triplicate Sputum Cultures for Efficacy Evaluation of Novel Antituberculosis Regimens.American journal of respiratory and critical care medicine · 2017
    Trial
  9. Trial
  10. Article
  11. Article
  12. Detection ofMicroorganisms · 2026
    Article
  13. Mechanisms ofBreathe (Sheffield, England) · 2026
    Review
  14. Article
  15. Article
  16. Ultrasensitive Enzyme-Free Detection of Proteins on Magnetic Beads.Journal of the American Chemical Society · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Being a woman researcher in dangerous laboratories: biosafety level 3 and tuberculosis.Philosophy, ethics, and humanities in medicine : PEHM · 2025
    Article

200 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Linda M ParsonsCenters for Disease Control and Prevention, Global AIDS Program, International Laboratory Branch, Atlanta, GA 30329, USA.
Akos Somoskövi
Cristina Gutierrez
Evan Lee
C N Paramasivan
Alash'le Abimiku
Steven Spector
Giorgio Roscigno
John Nkengasong
Foundation for Innovative New Diagnostics · CHCenters for Disease Control and Prevention · USAmerican Society for Microbiology · USUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With an estimated 9.4 million new cases globally, tuberculosis (TB) continues to be a major public health concern. Eighty percent of all cases worldwide occur in 22 high-burden, mainly resource-poor settings. This devastating impact of tuberculosis on vulnerable populations is also driven by its deadly synergy with HIV. Therefore, building capacity and enhancing universal access to rapid and accurate laboratory diagnostics are necessary to control TB and HIV-TB coinfections in resource-limited countries. The present review describes several new and established methods as well as the issues and challenges associated with implementing quality tuberculosis laboratory services in such countries. Recently, the WHO has endorsed some of these novel methods, and they have been made available at discounted prices for procurement by the public health sector of high-burden countries. In addition, international and national laboratory partners and donors are currently evaluating other new diagnostics that will allow further and more rapid testing in point-of-care settings. While some techniques are simple, others have complex requirements, and therefore, it is important to carefully determine how to link these new tests and incorporate them within a country's national diagnostic algorithm. Finally, the successful implementation of these methods is dependent on key partnerships in the international laboratory community and ensuring that adequate quality assurance programs are inherent in each country's laboratory network.

Indexed as

Clinical Laboratory TechniquesDeveloping CountriesHumansMedical Laboratory ScienceTuberculosis

Identifiers

PMID21482728
PMCPMC3122496
OpenAlexW2124344963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.